Report Detail

Pharma & Healthcare Global Alzheimer's Disease Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3775221
  • |
  • 24 September, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time.

Scope of the Report:
The worldwide market for Alzheimer's Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Alzheimer's Disease Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Eisai
Forest Laboratories
H. Lundbeck
Johnson and Johnson
Merz Pharma
Novartis
Pfizer

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Cholinesterase Inhibitors
NMDA Antagonists

Market Segment by Applications, can be divided into
Drug Stores
Retail Stores
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer's Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alzheimer's Disease Drugs, with price, sales, revenue and global market share of Alzheimer's Disease Drugs in 2017 and 2018.
Chapter 3, the Alzheimer's Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer's Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Alzheimer's Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Alzheimer's Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Alzheimer's Disease Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Cholinesterase Inhibitors
      • 1.2.2 NMDA Antagonists
    • 1.3 Market Analysis by Applications
      • 1.3.1 Drug Stores
      • 1.3.2 Retail Stores
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Eisai
      • 2.1.1 Business Overview
      • 2.1.2 Alzheimer's Disease Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Eisai Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Forest Laboratories
      • 2.2.1 Business Overview
      • 2.2.2 Alzheimer's Disease Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Forest Laboratories Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 H. Lundbeck
      • 2.3.1 Business Overview
      • 2.3.2 Alzheimer's Disease Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 H. Lundbeck Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Johnson and Johnson
      • 2.4.1 Business Overview
      • 2.4.2 Alzheimer's Disease Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Johnson and Johnson Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Merz Pharma
      • 2.5.1 Business Overview
      • 2.5.2 Alzheimer's Disease Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Merz Pharma Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Novartis
      • 2.6.1 Business Overview
      • 2.6.2 Alzheimer's Disease Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Novartis Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Pfizer
      • 2.7.1 Business Overview
      • 2.7.2 Alzheimer's Disease Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Pfizer Alzheimer's Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Alzheimer's Disease Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Alzheimer's Disease Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Alzheimer's Disease Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Alzheimer's Disease Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Alzheimer's Disease Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Alzheimer's Disease Drugs Market Analysis by Regions

    • 4.1 Global Alzheimer's Disease Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Alzheimer's Disease Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Alzheimer's Disease Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)

    5 North America Alzheimer's Disease Drugs by Country

    • 5.1 North America Alzheimer's Disease Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Alzheimer's Disease Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Alzheimer's Disease Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)

    6 Europe Alzheimer's Disease Drugs by Country

    • 6.1 Europe Alzheimer's Disease Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Alzheimer's Disease Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Alzheimer's Disease Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Alzheimer's Disease Drugs by Country

    • 7.1 Asia-Pacific Alzheimer's Disease Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Alzheimer's Disease Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Alzheimer's Disease Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)

    8 South America Alzheimer's Disease Drugs by Country

    • 8.1 South America Alzheimer's Disease Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Alzheimer's Disease Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Alzheimer's Disease Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Alzheimer's Disease Drugs by Countries

    • 9.1 Middle East and Africa Alzheimer's Disease Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Alzheimer's Disease Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Alzheimer's Disease Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Alzheimer's Disease Drugs Sales and Growth Rate (2014-2019)

    10 Global Alzheimer's Disease Drugs Market Segment by Type

    • 10.1 Global Alzheimer's Disease Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Alzheimer's Disease Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Alzheimer's Disease Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Cholinesterase Inhibitors Sales Growth and Price
      • 10.2.1 Global Cholinesterase Inhibitors Sales Growth (2014-2019)
      • 10.2.2 Global Cholinesterase Inhibitors Price (2014-2019)
    • 10.3 NMDA Antagonists Sales Growth and Price
      • 10.3.1 Global NMDA Antagonists Sales Growth (2014-2019)
      • 10.3.2 Global NMDA Antagonists Price (2014-2019)

    11 Global Alzheimer's Disease Drugs Market Segment by Application

    • 11.1 Global Alzheimer's Disease Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Drug Stores Sales Growth (2014-2019)
    • 11.3 Retail Stores Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Alzheimer's Disease Drugs Market Forecast (2019-2024)

    • 12.1 Global Alzheimer's Disease Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Alzheimer's Disease Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Alzheimer's Disease Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Alzheimer's Disease Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Alzheimer's Disease Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Alzheimer's Disease Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Alzheimer's Disease Drugs Market Forecast (2019-2024)
    • 12.3 Alzheimer's Disease Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Alzheimer's Disease Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Alzheimer's Disease Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Alzheimer's Disease Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Alzheimer's Disease Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Alzheimer's Disease Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Alzheimer's Disease Drugs. Industry analysis & Market Report on Alzheimer's Disease Drugs is a syndicated market report, published as Global Alzheimer's Disease Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Alzheimer's Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,818.80
      4,228.20
      5,637.60
      3,267.72
      4,901.58
      6,535.44
      538,564.80
      807,847.20
      1,077,129.60
      290,232.00
      435,348.00
      580,464.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report